Skip to main content
Log in

Elevation of lung surfactant phosphatidylcholine in mouse models of Sandhoff and of Niemann–Pick A disease

  • Published:
Journal of Inherited Metabolic Disease

Abstract

Summary: Sandhoff disease is caused by the defective activity of the lysosomal enzyme β-hexosaminidase, resulting in accumulation of the glycolipids, GA2 and GM2. Niemann–Pick A/B disease is caused by the defective activity of lysosomal acid sphingomyelinase resulting in sphingomyelin accumulation. Pulmonary complications have been observed in both diseases. We now demonstrate changes in phospholipid levels in pulmonary surfactant in mouse models of these diseases. In the Hexb mouse, a model of Sandhoff disease, lipid phosphate levels were elevated in surfactant from 3- and 4-month-old mice, which was mainly due to elevated levels of phosphatidylcholine. In the ASM mouse, a model of Niemann–Pick A disease, levels of the primary storage material, sphingomyelin, were elevated as expected, and levels of phosphatidylcholine and two other phospholipids were also significantly elevated in pulmonary surfactant and in lung tissue from 5-, 6- and 7-month-old mice. These results suggest that changes in phospholipid levels and composition in lung surfactant might be a general feature of sphingolipid storage diseases, which may be in part responsible for the increased susceptibility of these patients to respiratory infections and lung pathology, often the main reason for the death of these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  • Bartlett GR (1959) Phosphorus assay in column chromatography. J Biol Chem 234: 466–469.

    Google Scholar 

  • Bewig B, Wang XD, Kirsten D, Dalhoff K, Schafer H (2000) GM-CSF and GM-CSF beta c receptor in adult patients with pulmonary alveolar proteinosis. Eur Respir J 15: 350–357.

    Google Scholar 

  • Bodennec J, Brichon G, Zwingelstein G, Portoukalian J (2000a) Purification of sphingolipid classes by solid phase extraction with aminopropyl and weak cation exchanger cartridges. Methods Enzymol 312: 101–114.

    Google Scholar 

  • Bodennec J, Koul O, Aguado I, Brichon G, Zwingelstein G, Portoukalian J (2000b) A procedure for fractionation of sphingolipid classes by solid-phase extraction on aminopropyl cartridges. J Lipid Res 41: 1524–1531.

    Google Scholar 

  • Bodennec J, Pelled D, Riebeling C, Trajkovic S, Futerman AH (2002) Phosphatidylcholine synthesis is elevated in neuronal models of Gaucher disease due to direct activation of CTP: phosphocholine cytidylyltransferase by glucosylceramide. FASEB J 16: 1814–1816.

    Google Scholar 

  • Bradford M(1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248–254.

    Google Scholar 

  • Buccoliero R, Bodennec J, Van Echten-Deckert G, Sandhoff K, Futerman AH (2004) Phospholipid synthesis is decreased in neuronal tissue in a mouse model of Sandhoff disease. J Neurochem 90: 80–88.

    Google Scholar 

  • deMello DE, Lin Z (2001) Pulmonary alveolar proteinosis: a review. Pediatr PatholMol Med 20: 413–432.

    Google Scholar 

  • Dhami R, He X, Gordon RE, Schuchman EH (2001) Analysis of the lung pathology and alveolar macrophage function in the acid sphingomyelinase-deficient mouse model of Niemann-Pick disease. Lab Invest 81: 987–999.

    Google Scholar 

  • Duchateau F, Dechambre S, Coche E (2001) Imaging of pulmonary manifestations in subtype B of Niemann-Pick disease. Br J Radiol 74: 1059–1061.

    Google Scholar 

  • Ferretti GR, Lantuejoul S, Brambilla E, Coulomb M (1996) Case report. Pulmonary involvement in Niemann-Pick disease subtype B: CT findings. J Comput Assist Tomogr 20: 990–992.

    Google Scholar 

  • Folch J, Lees M, Stanley GHS (1957) A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226: 497–509.

    Google Scholar 

  • Gravel RA, Kaback MM, Proia R, Sandhoff K, Suzuki K, Suzuki K (2001) The GM2 gangliosidosis. In: Scriver CR, Sly WS, Beaudet AL, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc. eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 3827–3876.

    Google Scholar 

  • Green GM (1973) Alveolobronchiolar transport mechanisms. Arch Intern Med 131: 109–114.

    Google Scholar 

  • Gregory TJ, Longmore WJ, Moxley MA, et al (1991) Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 88: 1976–1981.

    Google Scholar 

  • Gunther A, Siebert C, Schmidt R, et al (1996) Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am J Respir Crit Care Med 153: 176–184.

    Google Scholar 

  • Heppleston AG, McDermottM, CollinsMM(1975) The surface properties of the lung in rats with alveolar lipo-proteinosis. Br J Exp Pathol 56: 444–453.

    Google Scholar 

  • Horinouchi K, Erlich S, Perl DP, et al (1995) Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease. Nature Genetics 10: 288–293.

    Google Scholar 

  • Ikegami M, Ueda T, Hull W, et al (1996) Surfactant metabolism in transgenic mice after granulocyte macrophage-colony stimulating factor ablation. Am J Physiol 270: L650–658.

    Google Scholar 

  • Ikegami M, Dhami R, Schuchman EH (2003) Alveolar lipoproteinosis in an acid sphingomyelinase-deficient mouse model of Niemann-Pick disease. Am J Physiol Lung Cell Mol Physiol 284: L518–525.

    Google Scholar 

  • Kuemmel TA, Thiele J, Schroeder R, Stoffel W (1997) Pathology of visceral organs and bone marrow in an acid sphingomyelinase deficient knock-out mouse line, mimicking human Niemann-Pick disease type A. A light and electron microscopic study. Pathol Res Pract 193: 663–671.

    Google Scholar 

  • Lever AM, Ryder JB (1983) Cor pulmonale in an adult secondary to Niemann-Pick disease. Thorax 38: 873–874.

    Google Scholar 

  • Lewis JF, Jobe AH (1993) Surfactant and the adult respiratory distress syndrome. Am Rev Respir Dis 147: 218–233.

    Google Scholar 

  • Minai OA, Sullivan EJ, Stoller JK (2000) Pulmonary involvement in Niemann-Pick disease: case report and literature review. Respir Med 94: 1241–1251.

    Google Scholar 

  • Nicholson AG, Wells AU, Hooper J, Hansell DM, Kelleher A, Morgan C (2002) Successful treatment of endogenous lipoid pneumonia due to Niemann-Pick Type B disease with whole-lung lavage. Am J Respir Crit Care Med 165: 128–131.

    Google Scholar 

  • Niggemann B, Rebien W, Rahn W, Wahn U (1994) Asymptomatic pulmonary involvement in 2 children with Niemann-Pick disease type B. Respiration 61: 55–57.

    Google Scholar 

  • Pelled D, Riebeling C, Van Echten-Deckert G, Sandhoff K, Futerman AH (2003a) Reduced rates of axonal and dendritic growth in embryonic hippocampal neurones cultured from a mouse model of Sandhoff disease. Neuropathol Appl Neurobiol 29: 341–349.

    Google Scholar 

  • Pelled D, Lloyd-Evans E, Riebeling C, Jeyakumar M, Platt FM, Futerman AH (2003b) Inhibition of calcium uptake via the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) in a mouse model of Sandhoff disease, and prevention by treatment with N-butyldeoxynojirimycin. J Biol Chem 278: 29496–29501.

    Google Scholar 

  • Possmayer F, Yu SH, Weber JM, Harding PG (1984) Pulmonary surfactant. Can J Biochem Cell Biol 62: 1121–1133.

    Google Scholar 

  • Sango K, Yamanaka S, Hoffmann A, et al (1995) Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism. Nature Genetics 11: 170–176.

    Google Scholar 

  • Schnaar RL (1994) Isolation of glycosphingolipids. Methods Enzymol 230: 348–370.

    Google Scholar 

  • Schuchman EH, Desnick RJ (2001) Niemann-Pick disease types A and B: acid sphingomyelinase deficiencies. In: Scriver CR, Sly WS, Beaud et al, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 3589–3610.

    Google Scholar 

  • Seeger W, Gunther A, Walmrath HD, Grimminger F, Lasch HG (1993) Alveolar surfactant and adult respiratory distress syndrome. Pathogenetic role and therapeutic prospects. Clin Invest 71: 177–190.

    Google Scholar 

  • Seymour JF, Presneill JJ (2002) Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med 166: 215–235.

    Google Scholar 

  • Trajkovic-Bodennec S, Bodennec J, Futerman AH (2004) Phosphatidylcholine metabolism is altered in a monocyte-derived macrophage model of Gaucher disease but not in lymphocytes. Blood Cells Mol Dis 33: 77–82.

    Google Scholar 

  • Tredano M, De Blic J, Griese M, Fournet JC, Elion J, Bahuau M (2001) Clinical biological and genetic heterogeneity of the inborn errors of pulmonary surfactant metabolism. Clin Chem Lab Med 39: 90–108.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Buccoliero, R., Ginzburg, L. & Futerman> , A.H. Elevation of lung surfactant phosphatidylcholine in mouse models of Sandhoff and of Niemann–Pick A disease. J Inherit Metab Dis 27, 641–648 (2004). https://doi.org/10.1023/B:BOLI.0000042958.22066.6c

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:BOLI.0000042958.22066.6c

Keywords

Navigation